Clinical, Pathologic, and Scintigraphic Findings in Patients Presenting with Primary Untreated Breast Carcinoma
Patient no. | Age (y) | Histology | Size | TNM stage | ER | PR | GRP-R H score | Diff. | T/N ratio |
---|---|---|---|---|---|---|---|---|---|
1 | 37 | Inv. lob. | 6.0 | T3 N1 M0 | 0 | 0 | 15 | Poor | 9.5 |
2 | 46 | Inv. lob. | 5.5 | T3 N2 M0 | 0 | 0 | 2 | Moderate | 2.1 |
3 | 63 | Inv. lob. | 1.5 | T1 N0 M0 | 90 | 90 | 4 | Poor | 1.8 |
4 | 69 | Inv. duct. | 4.0 | T2 N1 M0 | 75 | 60 | 6 | Moderate | 4.5 |
5 | 44 | Inv. duct. | 5.4 | T3 N1 MO | 0 | 0 | 8 | Moderate | 4.6 |
6 | 41 | Inv. lob. | 3.5 | T2 N1 M0 | 90 | 80 | 12 | Poor | 11 |
7 | 75 | Inv. duct. | 5.6 | T4 N1 M0 | 95 | 0 | 12 | Poor | 8.2 |
8 | 51 | Inv. lob. | 3.0 | T2 N3 M1 | 90 | 50 | 2 | Moderate | 1 |
9 | 65 | Inv. lob. | 4.0 | T4 N3 M1 | 98 | 5 | 15 | Moderate | 14 |
Size = largest-diameter primary tumor; TNM = tumor–node–metastasis stage; ER = ER status; PR = PR status; GRP-R H score = histologic GRP-R score; Diff. = degree of differentiation of primary tumor; T/N ratio = ratio of tumor to normal tissue; Inv. lob. = invasive lobular carcinoma; Inv. duct. = invasive ductal carcinoma.